Filing Details
- Accession Number:
- 0000914190-20-000160
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-04 16:35:35
- Reporting Period:
- 2020-04-30
- Accepted Time:
- 2020-05-04 16:35:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 842023 | Bio-Techne Corp | TECH | Biological Products, (No Disgnostic Substances) (2836) | 411427402 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197788 | J Harold Wiens | 614 Mckinley Place Ne Minneapolis MN 55413 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-30 | 4,000 | $91.78 | 9,221 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-30 | 4,000 | $225.00 | 5,221 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-04-30 | 4,000 | $0.00 | 4,000 | $91.78 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-10-30 | 2024-10-30 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $87.34 | 2016-10-29 | 2025-10-28 | 4,260 | 4,260 | Direct |
| Common Stock | Stock Option (right to buy) | $101.19 | 2017-10-26 | 2026-10-26 | 3,985 | 3,985 | Direct |
| Common Stock | Stock Option (right to buy) | $125.05 | 2018-10-25 | 2027-10-26 | 3,125 | 3,125 | Direct |
| Common Stock | Stock Option (right to buy) | $179.84 | 2019-10-24 | 2028-10-25 | 1,898 | 1,898 | Direct |
| Common Stock | Stock Option (right to buy) | $201.64 | 2029-10-24 | 2,011 | 2,011 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2025-10-28 | 4,260 | 4,260 | Direct |
| 2026-10-26 | 3,985 | 3,985 | Direct |
| 2027-10-26 | 3,125 | 3,125 | Direct |
| 2028-10-25 | 1,898 | 1,898 | Direct |
| 2029-10-24 | 2,011 | 2,011 | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2019.
- The option vests on the earlier of the one year anniversary of the grant date (10/24/2019) or the date of Bio-Techne's 2020 annual meeting of shareholders.
Billionaire Hedge Funds
